Bronze
MastBio is a pioneer for IVD testing in South Korea established in 1996. During the last 26 years, we have focused on discovering and supplying high quality reagent for IVD and R&D - Hospitals affiliated with medical school, major clinical laboratory, pharmaceutical company, bio-venture company, university and the National Institutes of Health. We are continuously going to make efforts to expand the supply chains and diversify our products. We have concluded exclusive supply contracts with more than 20 IVD and R&D companies all over the world and experimental equipment companies to supply excellent products in the country.
C. difficile infection usually occurs when the normal microflora of the intestinal tract is altered or killed by antibiotics. Once C. difficile growth begins, toxins A and B are produced, causing diarrhea and colitis. Toxigenic strains of C. difficile carry the genes encoding the toxins. The disease results from the toxins that the organism produces. C. difficile produces two main toxins, toxin A and toxin B. Toxin A is a weakly cytotoxic enterotoxin. C. difficile also produces toxin B, which is a cytotoxin. Toxin B can be detected by the tissue culture assay. Toxigenic C. difficile strains produce both toxins or only toxin B. The disease can be treated with antibiotics, but relapses are common. The C. DIFF QUIK CHEK COMPLETE ® test is a rapid membrane enzyme immunoassay for the simultaneous detection of Clostridium difficile glutamate dehydrogenase antigen and toxins A and B in a single reaction well. The test is to be used as an aid in the diagnosis of C. difficile disease.
D-
Booth No.